Detalles de la búsqueda
1.
Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study.
J Rheumatol
; 39(12): 2238-46, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23027887
2.
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Arthritis Rheum
; 54(9): 2793-806, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16947627
Resultados
1 -
2
de 2
1
Próxima >
>>